Table 2. Patient demographics.

Characteristic	Total (N=21)	%
Gender
Male	16	76.2
Female	5	23.8
Age (years)
Median	59
Karnofsky performance status
60	1	4.8
70	2	9.5
80	5	23.8
90	13	61.9
Primary tumour location
Lower one-third of oesophagus	5	23.8
OGJ	7	33.3
Gastric	9	42.9
Adenocarcinoma	21	100
Stage (AJCC)
IIIb	1	5
IV	20	95

ECX=epirubicin, cisplatin and capecitabine; OGJ=oesophagogastric junction.